MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Cash Flow Overview
Free Cash flow
-$3,236K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
Non-cash lease expense
Prepaid expenses and other asset...
Depreciation and amortization
Accounts receivable
Negative Cash Flow Breakdown
Gain on change in fair value of ...
Net loss
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net loss
-1,338
-5,764
-2,691
-2,545
Loss on issuance of common stock
-
-2,703
-
-
Placement agent warrant offering expense
-
138
-
-
Gain on previously liquidated equity securities
-
94
-
-
Gain on sale of asset
-
0
-
-
Gain on change in fair value of common stock warrant liabilities
1,400
-
-
-
Interest accretion on escrow receivable
2
3
3
4
Accretion on investments
-
0
0
0
Inventory write-off
-
0
0
0
Depreciation and amortization
40
43
52
59
Stock-based compensation
91
86
67
72
Non-cash lease expense
120
118
116
114
Accounts receivable
-3
-1
1
0
Inventory
-
0
0
0
Prepaid expenses and other assets
-47
-151
-174
-97
Accounts payable
-400
350
91
-93
Accrued expenses
-243
163
47
44
Operating lease liabiliy
-131
-130
-123
-122
Net cash used in operating activities
-3,213
-2,238
-2,271
-2,378
Purchases of fixed assets
23
0
0
0
Proceeds from sale of asset
-
0
-
-
Purchases of investments
-
0
0
0
Maturities of investments
-
0
0
0
Proceeds from previously liquidated equity securities
-
94
-
-
Net cash used in investing activities
-23
94
0
0
Proceeds from issuance of common stock, net
0
2,997
0
0
Repayment of insurance premium financing liability
118
117
118
0
Net cash (used in) provided by financing activities
-118
2,880
-118
0
Net decrease in cash, cash equivalents, and restricted cash
-3,354
736
-2,389
-2,378
Cash, cash equivalents, and restricted cash at beginning of period
5,167
6,820
6,820
11,455
Cash, cash equivalents, and restricted cash at end of period
1,813
-
-
-
Cash and cash equivalents
1,670
-
-
-
Restricted cash
143
-
-
-
Cash, cash equivalents, and restricted cash at end of period
1,813
5,167
4,431
6,820
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Cash Flow
Net decrease in
cash, cash...
-$3,354K
(-48.60%↓ Y/Y)
Non-cash lease expense
$120K
(7.14%↑ Y/Y)
Stock-based compensation
$91K
(16.67%↑ Y/Y)
Prepaid expenses and
other assets
-$47K
(81.05%↑ Y/Y)
Depreciation and
amortization
$40K
(-34.43%↓ Y/Y)
Accounts receivable
-$3K
(-250.00%↓ Y/Y)
Net cash used in
operating activities
-$3,213K
(18.45%↑ Y/Y)
Net cash (used in)
provided by financing...
-$118K
(-107.01%↓ Y/Y)
Net cash used in
investing activities
-$23K
Canceled cashflow
$301K
Gain on change in fair
value of common stock...
$1,400K
Net loss
-$1,338K
(52.94%↑ Y/Y)
Accounts payable
-$400K
(58.81%↑ Y/Y)
Accrued expenses
-$243K
(51.30%↑ Y/Y)
Repayment of insurance
premium financing...
$118K
(-7.81%↓ Y/Y)
Purchases of fixed assets
$23K
Operating lease liabiliy
-$131K
(-9.17%↓ Y/Y)
Interest accretion on
escrow receivable
$2K
(-50.00%↓ Y/Y)
Buy us a coffee
VivoSim Labs, INC. (VIVS)
VivoSim Labs, INC. (VIVS)